ES7R
TEAS SECTION 7 REQUEST RECEIVED
29/07/2026
Voltar para busca
Dado oficial do USPTO
PROVOLUT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
17
Atualização mais recente
29/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
03/07/2025
Data de registro
09/06/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/06/2026
Última transação
29/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
27
Localização do titular
Berlin, DE
Examinador
JONES, JACQUELYN ANDREA
Unidade examinadora
N20
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Exazyme GmbH
Representantes
KATRIN LEWERTOFF LEWERTOFF IP LAW GROUP, LLC
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Recorded and downloadable media and datarecorded and downloadable datasets comprising protein sequencestructurefunction data for use in biotechnology and pharmaceutical research; Downloadable databases in the field of protein engineeringmolecular biologydrug discovery; Downloadable software for computational protein designprotein engineeringmolecular simulationoptimization of proteinsenzymesmolecules for pharmaceutical and industrial biotechnology applications; Downloadable artificial intelligence software for protein designprotein optimizationdrug candidate identificationprediction of protein properties and downloadable software using machine learning for designinganalyzingoptimizingpredicting the function and properties of proteinsenzymesmolecules for use in pharmaceutical development and biotechnology; all the aforesaid goods relating toin particularsynthetic biologybiotechnologyprotein engineeringmolecular sciences and the designdevelopment and optimization of proteinsenzymes and molecules
Classe 42
IT servicesIT consulting services relating to the implementationintegrationmaintenancecustomization of software for computational biologyprotein engineeringdrug design; developmentprogramming and implementation of software for others; hosting serviceshosting cloud-based software platforms for computational protein designmolecular simulationdrug discovery; platform-as-a-service (PaaS) featuring computer software platforms for computational protein engineeringmachine-learning-driven protein optimizationpharmaceutical drug candidate design and analysis; software-as-a-service (SaaS) services featuring software for AI-driven protein designprotein optimizationmolecular engineeringdrug discovery; rental of computer software for computational protein designprotein optimizationmolecular simulationdrug development; design and development of computer hardware and software; scientific and technological servicesscientific researchcomputational analysistesting in the field of protein engineeringmolecular biologydrug discoverybiotechnology and scientific and technological research in the field of protein designenzyme engineeringdrug developmentprecision oncology and design services relating theretocomputational protein designenzyme designdrug candidate designsoftware design for biotechnology applications; industrial research in the field of biotechnologyprotein engineeringindustrial enzyme development and industrial design services; quality control of goods and services and authentication in the field of protein and enzyme qualitypharmaceutical drug candidatesbiotechnological products; development of pharmaceutical products; Scientific laboratory services; laboratory research in the field of protein engineeringmolecular biologyenzyme optimizationpharmaceutical drug development; Scientific laboratory services; Computer software consultancyinformation and information services in the field of computational biologyprotein engineeringdrug designbiotechnology relating to the aforementioned services; all of the aforementioned servicesin particularin the field of synthetic biologybiotechnologyprotein technologymolecular sciences and for the designdevelopment and optimization of proteinsenzymes and molecules
Publicações
Histórico de despachos e eventos da marca no USPTO.
17 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/06/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
09/06/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/04/2026
PUBO
PUBLISHED FOR OPPOSITION
21/04/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/03/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/02/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/02/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/02/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/11/2025
GNRT
NON-FINAL ACTION E-MAILED
24/11/2025
CNRT
NON-FINAL ACTION WRITTEN
24/11/2025
DOCK
ASSIGNED TO EXAMINER
21/11/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/11/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/07/2025
NWAP
NEW APPLICATION ENTERED
03/07/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PROVOLUT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.